Decreased Frontal Lobe Gray Matter Perfusion in Cognitively Impaired Patients with Secondary-Progressive Multiple Sclerosis Detected by the Bookend Technique

References

1. 1.↵
   1. Huijbregts SCJ,
   2. Kalkers NF,
   3. de Sonneville LMJ,
   4. et al

   . Differences in cognitive impairment of relapsing remitting, secondary, and primary progressive MS. Neurology 2004; 63: 335– 39

   Abstract/FREE Full Text
2. 2.↵
   1. Rao SM,
   2. Leo GJ,
   3. Ellington L,
   4. et al

   . Cognitive dysfunction in multiple sclerosis. II. Impact on employment and social functioning. Neurology 1991; 41: 692– 96

   Abstract/FREE Full Text
3. 3.↵
   1. Filippi M,
   2. Horsfield MA,
   3. Hajnal JV,
   4. et al

   . Quantitative assessment of magnetic resonance imaging lesion load in multiple sclerosis. J Neurol Neurosurg Psychiatry 1998; 64: S88– 93

   PubMedWeb of Science
4. 4.↵
   1. Rovaris M,
   2. Bozzali M,
   3. Iannucci G,
   4. et al

   . Assessment of normal-appearing white and gray matter in patients with primary progressive multiple sclerosis: a diffusion-tensor magnetic resonance imaging study. Arch Neurol 2002; 59: 1406– 12

   CrossRefPubMedWeb of Science
5. 5.↵
   1. Dehmeshki J,
   2. Chard DT,
   3. Leary SM,
   4. et al

   . The normal appearing grey matter in primary progressive multiple sclerosis: a magnetisation transfer imaging study. J Neurol 2003; 250: 67– 74

   CrossRefPubMedWeb of Science
6. 6.↵
   1. Fog T

   . On the vessel-plaque relationships in the brain in multiple sclerosis. Acta Neurol Scand Suppl 1964; 40: 9– 15

   PubMed
7. 7.↵
   1. Tanaka R,
   2. Iwasaki Y,
   3. Koprowski H

   . Ultrastructural studies of perivascular cuffing cells in multiple sclerosis brain. Am J Pathol 1975; 81: 467– 78

   PubMedWeb of Science
8. 8.↵
   1. Adams CW,
   2. Poston RN,
   3. Buk SJ,
   4. et al

   . Inflammatory vasculitis in multiple sclerosis. J Neurol Sci 1985; 69: 269– 83

   CrossRefPubMedWeb of Science
9. 9.↵
   1. Adams RA,
   2. Passino M,
   3. Sachs BD,
   4. et al

   . Fibrin mechanisms and functions in nervous system pathology. Mol Interv 2004; 4: 163– 76

   PubMedWeb of Science
10. 10.↵
    1. Filippi M,
    2. Rocca MA,
    3. Benedict RH,
    4. et al

    . The contribution of MRI in assessing cognitive impairment in multiple sclerosis. Neurology 2010; 75: 2121– 28

    Abstract/FREE Full Text
11. 11.↵
    1. Rovaris M,
    2. Comi G,
    3. Filippi M

    . MRI markers of destructive pathology in multiple sclerosis-related cognitive dysfunction. J Neurol Sci 2006; 245: 111– 16

    CrossRefPubMedWeb of Science
12. 12.↵
    1. Calabrese M,
    2. Agosta F,
    3. Rinaldi F,
    4. et al

    . Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis. Arch Neurol 2009; 66: 1144– 50

    CrossRefPubMedWeb of Science
13. 13.↵
    1. Roosendaal SD,
    2. Moraal B,
    3. Pouwels PJ,
    4. et al

    . Accumulation of cortical lesions in MS: relation with cognitive impairment. Mult Scler 2009; 15: 708– 14

    Abstract/FREE Full Text
14. 14.↵
    1. Carroll TJ,
    2. Horowitz S,
    3. Shin W,
    4. et al

    . Quantification of cerebral perfusion using the “bookend technique”: an evaluation in CNS tumors. Magn Reson Imaging 2008; 26: 1352– 59

    CrossRefPubMed
15. 15.↵
    1. Shin W,
    2. Cashen TA,
    3. Horowitz SW,
    4. et al

    . Quantitative CBV measurement from static T1 changes in tissue and correction for intravascular water exchange. Magn Reson Med 2006; 56: 138– 45

    CrossRefPubMed
16. 16.↵
    1. Shin W,
    2. Horowitz S,
    3. Ragin A,
    4. et al

    . Quantitative cerebral perfusion using dynamic susceptibility contrast MRI: evaluation of reproducibility and age- and gender-dependence with fully automatic image postprocessing algorithm. Magn Reson Med 2007; 58: 1232– 41

    CrossRefPubMed
17. 17.↵
    1. Lee JJ,
    2. Parikh V,
    3. Shin W,
    4. et al

    . Validation of quantitative cerebral blood flow measurements by MR imaging and the bookend technique using positron emission tomography. In: Proceedings of the American Society of Neuroradiology Vancouver, British Columbia, Canada; 2009
18. 18.↵
    1. Benedict RH,
    2. Bakshi R,
    3. Simon JH,
    4. et al

    . Frontal cortex atrophy predicts cognitive impairment in multiple sclerosis. J Neuropsychiatry Clin Neurosci 2002; 14: 44– 51

    CrossRefPubMedWeb of Science
19. 19.↵
    1. Benedict RHB,
    2. Zivadinov R

    . Predicting neuropsychological abnormalities in multiple sclerosis. J Neurol Sci 2006; 245: 67– 72

    CrossRefPubMedWeb of Science
20. 20.↵
    1. Sakaie KE,
    2. Shin W,
    3. Curtin KR,
    4. et al

    . Method for improving the accuracy of quantitative cerebral perfusion imaging. J Magn Reson Imaging 2005; 21: 512– 19

    CrossRefPubMed
21. 21.↵
    1. Kim YR,
    2. Rebro KJ,
    3. Schmainda KM

    . Water exchange and inflow affect the accuracy of T1-GRE blood volume measurements: implications for the evaluation of tumor angiogenesis. Magn Reson Med 2002; 47: 1110– 20

    CrossRefPubMed
22. 22.↵
    1. Wu S,
    2. Thornhill RE,
    3. Chen S,
    4. et al

    . Relative recirculation: a fast, model-free surrogate for the measurement of blood-brain barrier permeability and the prediction of hemorrhagic transformation in acute ischemic stroke. Invest Radiol 2009; 44: 662– 68

    CrossRefPubMed
23. 23.↵
    1. Tisserand DJ,
    2. Pruessner JC,
    3. Sanz Arigita EJ,
    4. et al

    . Regional frontal cortical volumes decrease differentially in aging: an MRI study to compare volumetric approaches and voxel-based morphometry. Neuroimage 2002; 17: 657– 69

    CrossRefPubMedWeb of Science
24. 24.↵
    1. Nelder J,
    2. Wedderburn R

    . Generalized linear models. J R Statist Soc A 1972; 135: 370– 84

    CrossRef
25. 25.↵
    1. Inglese M,
    2. Adhya S,
    3. Johnson G,
    4. et al

    . Perfusion magnetic resonance imaging correlates of neuropsychological impairment in multiple sclerosis. J Cereb Blood Flow Metab 2008; 28: 164– 71

    CrossRefPubMed
26. 26.↵
    1. Paulesu E,
    2. Perani D,
    3. Fazio F,
    4. et al

    . Functional basis of memory impairment in multiple sclerosis: A[18F]FDG PET study. Neuroimage 1996; 4: 87– 96

    CrossRefPubMedWeb of Science
27. 27.↵
    1. Alexander MP,
    2. Stuss DT,
    3. Picton T,
    4. et al

    . Regional frontal injuries cause distinct impairments in cognitive control. Neurology 2007; 68: 1515– 23

    Abstract/FREE Full Text
28. 28.↵
    1. Stuss DT,
    2. Alexander MP

    . Is there a dysexecutive syndrome? Philos Trans R Soc Lond B Biol Sci 2007; 362: 901– 15

    Abstract/FREE Full Text
29. 29.↵
    1. Ge Y,
    2. Zohrabian VM,
    3. Osa EO,
    4. et al

    . Diminished visibility of cerebral venous vasculature in multiple sclerosis by susceptibility-weighted imaging at 3.0 Tesla. J Magn Reson Imaging 2009; 29: 1190– 94

    CrossRefPubMed
30. 30.↵
    1. Nordstrom CH

    . The Lund concept: is this logical? Acta Neurochir Suppl 2005; 95: 475– 80

    CrossRefPubMed
31. 31.↵
    1. Asgeirsson B,
    2. Grande PO,
    3. Nordstrom CH,
    4. et al

    . Cerebral haemodynamic effects of dihydroergotamine in patients with severe traumatic brain lesions. Acta Anaesthesiol Scand 1995; 39: 922– 30

    CrossRefPubMed
32. 32.↵
    1. Sibson NR,
    2. Blamire AM,
    3. Perry VH,
    4. et al

    . TNF-alpha reduces cerebral blood volume and disrupts tissue homeostasis via an endothelin- and TNFr2-dependent pathway. Brain 2002; 125: 2446– 59

    Abstract/FREE Full Text
33. 33.↵
    1. Hoffmann S,
    2. Tittgemeyer M,
    3. von Cramon DY

    . Cognitive impairment in multiple sclerosis. Curr Opin Neurol 2007; 20: 275– 80

    CrossRefPubMedWeb of Science